Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

150.42

Aug 18 • 3:59 PM ET -3.10 (-2.02%)

150.42

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.17B
Enterprise Value	1.94B
Income	-61.70M
Sales	0.00M
Book/sh	15.06
Cash/sh	17.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.98
P/C	8.65
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	21.18
Current Ratio	21.18
Debt/Eq	0.10
LT Debt/Eq	0.10
Option/Short	Yes / Yes

EPS (ttm)	-4.84
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-75.53%
EPS next Y	-19.92%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	61.66%
Sales Y/Y TTM	-
EPS Q/Q	-77.78%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	36.96%
Insider Trans	-0.36%
Inst Own	88.09%
Inst Trans	33.38%
ROA	-37.70%
ROE	-46.63%
ROIC	-25.78%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	1.01%
SMA50	8.22%
SMA200	31.65%
Trades

Shs Outstand	14.40M
Shs Float	9.08M
Short Float	22.78%
Short Ratio	8.22
Short Interest	2.07M
52W High	161.38 -6.79%
52W Low	46.08 226.43%
Volatility	3.83% 7.09%
ATR (14)	8.41
RSI (14)	52.32
Beta	-0.23
Rel Volume	0.59
Avg Volume	251.55K
Volume	148,004

Perf Week	-2.51%
Perf Month	21.16%
Perf Quarter	43.19%
Perf Half Y	87.81%
Perf YTD	43.71%
Perf Year	203.57%
Perf 3Y	564.63%
Perf 5Y	-52.99%
Perf 10Y	15.35%
Recom	1.00
Target Price	229.82
Prev Close	153.52
Price	150.42
Change %	-2.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)